Chardan Healthcare Acquisition Corp. announced that it has entered into a definitive agreement for a business combination with BiomX Ltd. Assuming no redemption of CHAC shareholders, the combined company will have an initial market capitalization of approximately $254 million. Upon closing of the transaction, it is expected that CHAC will be renamed BiomX and remain on the NYSE American Stock Exchange, listed under a new ticker symbol. Post-closing, Mr. Jonathan Solomon and three current BiomX directors will join Mr. Jonas Grossman and Dr. Gbola Amusa from CHAC on the seven-person board of directors. An additional board member will be designated by BiomX.